Navigation

Search This Site

Office of the Vice President for Research

Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications

Sponsor: 
National Institutes of Health
Deadline Notes: 
This notice applies to due dates on or after January 19, 2021 and subsequent receipt dates through January 18, 2024.
Description: 

The purpose of this Notice of Special Interest (NOSI) is to announce that the National Center for Complementary and Integrative Health (NCCIH), the National Cancer Institute (NCI), the National Institute of Aging (NIA), the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of General Medical Sciences (NIGMS, and the National Human Genome Research Institute ( NHGRI ) are encouraging new applications to advance research activities relevant to synthetic biology.

Issued by:
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute on Aging (NIA)
National Institute of Allergy and Infectious Diseases (NIAID)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute of General Medical Sciences (NIGMS)
National Center for Complementary and Integrative Health (NCCIH)
National Cancer Institute (NCI)
National Human Genome Research Institute Home (NHGRI)

Application and Submission Information

Applicants must select the IC and associated FOA to use for submission of an application in response to this NOSI. The selection must align with the IC requirements listed in order to be considered responsive to that FOA. Non-responsive applications will be withdrawn from consideration for this initiative. In addition, applicants using NIH Parent Announcements (listed below) will be assigned to those ICs on this NOSI that have indicated those FOAs are acceptable and based on usual application-IC assignment practices.

This notice applies to due dates on or after January 19, 2021 and subsequent receipt dates through January 18, 2024.

Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.

FOA

Title

First Available Due Date

Expiration Date

Participating IC(s)

PA-20-183

NIH Research Project Grant (Parent R01 Clinical Trial Required)

February 5, 2021

May 8, 2023

NCCIH; NIA; NIAID

PA-20-185

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

February 5, 2021

May 8, 2023

NCCIH; NCI; NHGRI; NIA; NIAID; NIBIB; NICHD; NIGMS

PAR-20-084

NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)

February 16, 2021

January 8, 2023

NIBIB

PAR-19-367

Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)

January 19, 2021

May 18, 2022

NIGMS

PAR-20-117

Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (R35 - Clinical Trial Optional)

October 4, 2021

October 4, 2022

NIGMS

PA-18-482

NICHD Exploratory/Developmental Research Grant (R21 - Clinical Trial Optional)

February 16, 2021

January 8, 2021

NICHD

Word Cloud: